Endocyte to Present at Jefferies Healthcare Conference
May 29, 2018 16:30 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., May 29, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced...
Endocyte Announces Presentation of Phase 2 Data from Investigator-Initiated Prostate Cancer Trial of 177Lu-PSMA-617 at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
May 16, 2018 18:05 ET
|
Endocyte, Inc.
– PSA response rates in additional 20 mCRPC patients enrolled at Peter MacCallum Cancer Centre higher than previously reported for first group of 30 patients – – Company to host and webcast...
Endocyte Announces The Lancet Oncology Publication of Phase 2 Data From Investigator-Initiated Prostate Cancer Trial of (177)Lu-PSMA-617
May 09, 2018 08:01 ET
|
Endocyte, Inc.
-Publication includes analysis of original 30 patients previously presented at 2017 ESMO by Professor Michael Hofman of Peter MacCallum Cancer Centre- -Relative to previously presented...
Endocyte Provides First Quarter 2018 Financial Results and Operational Update
May 09, 2018 08:01 ET
|
Endocyte, Inc.
-Recently Updated Phase 2 Data on 177Lu-PSMA-617 Published in The Lancet Oncology Favorable to Preliminary Data Presented at 2017 ESMO Congress- -Positive End of Phase 2 FDA Meeting Set...
Endocyte Announces First Quarter 2018 Earnings Call
May 02, 2018 08:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., May 02, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today...
Endocyte to Present at Deutsche Bank's 43rd Annual Health Care Conference
May 01, 2018 16:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., May 01, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced...
Endocyte Presents Data from its CAR T Platform at American Association for Cancer Research (AACR) Annual Meeting 2018
April 16, 2018 09:00 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., April 16, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced...
Endocyte Announces Presentations at American Association for Cancer Research (AACR) Annual Meeting 2018
March 15, 2018 16:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., March 15, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced...
Endocyte Nominates Dawn Svoronos for Election to Its Board of Directors and Announces Other Board Developments
March 15, 2018 08:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., March 15, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced...
Endocyte to Present at the Cowen and Company 38th Annual Health Care Conference
March 05, 2018 16:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, March 05, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment , today announced that...